Tiziana Life Sciences (TLSA) Short term Debt (2018 - 2021)

Tiziana Life Sciences (TLSA) has reported Short term Debt for 4 consecutive years, with $1.4 million the latest figure, recorded in Q4 2021.

• Quarterly Short term Debt fell 31.27% year-over-year to $1.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.4 million (down 31.27% YoY) and the FY2021 annual result came in at $1.4 million, down 29.33% from the prior year.
• Short term Debt retreated to $1.4 million in Q4 2021 per TLSA's latest filing, from $1.6 million in the prior quarter.
• Over the last five years, Short term Debt for TLSA reached as high as $2.0 million in Q4 2020 and fell as low as $401067.7 in Q2 2020.
• A 4-year average of $978506.3 and a median of $579861.9 in 2019 frame the typical range for Short term Debt.
• The largest YoY upside for Short term Debt was 292.95% in 2021 against a maximum downside of 31.27% in 2021.
• Year by year, Short term Debt stood at $452942.1 in 2018, then gained by 28.02% to $579861.9 in 2019, then soared by 239.98% to $2.0 million in 2020, then tumbled by 31.27% to $1.4 million in 2021.
• According to Business Quant data, Short term Debt over the past three periods registered $1.4 million, $1.6 million, and $2.0 million for Q4 2021, Q2 2021, and Q4 2020 respectively.